Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP
x

Main navigation

  • Home +
    • About Us
  • Curriculum +
    • Content view
    • List View
  • Knowledge Map +
    • Knowledge Map Summary
  • Documents
  • Page Library +
    • Content Page Summary
x

Management of DR-TB ADR

  1. Home ›
  2. ›
  3. Management of DR-TB ADR
Node Status
Pending Review

Node Status

  • Pending Review
Learning Objectives

 

 

Sub Nodes

  • Management of DR-TB ADR: Giddiness
  • Management of DR-TB ADR: Hematological Abnormalities
  • Management of DR-TB ADR: Hypothyroidism
  • Management of DR-TB ADR: Arthralgia
  • Management of DR-TB ADR: Depression
  • Management of DR-TB ADR: Psychotic Symptoms
  • Management of DR-TB ADR: Suicidal Ideation
  • Management of DR-TB ADR: Seizures
  • Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity]
  • Management of DR-TB ADR: Gynecomastia
  • Management of DR-TB ADR: QT Prolongation
  • Management of DR-TB ADR: Rash, Allergy and Anaphylaxis Reaction
  • Management of DR-TB ADR: Hepatitis
  • Management of DR-TB ADR: Peripheral Neuropathy
  • Management of DR-TB ADR: Vestibular Toxicity
  • Management of DR-TB ADR: Optic Neuritis
  • Management of DR-TB ADR: Electrolyte Disturbances
  • Management of DR-TB ADR: Alopecia
  • Management of DR-TB ADR: Superficial Fungal Infection and Thrush
  • Management of DR-TB ADR: Lactic Acidosis
  • Management of DR-TB ADR: Dysglycaemia and Hyperglycemia
  • Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen
  • Adverse Drug Events: H Mono/Poly DR-TB Regimen
  • Management of Hepato-toxicity During Treatment with Shorter/Longer Oral MDR-TB Regimen
Linked Nodes
Treatment of Drug-resistant TB

Linked Content Page

No content linked currently.
Add Content Page


© 2026 Knowledge Base, All rights reserved.

User account menu

  • Log in
⇡